Respana Therapeutics, Inc
Developer of Novel Therapeutics for the Treatment of Acute Respiratory Conditions
Philadelphia, United States · Founded 2018 · $31.6M raised
- Headquarters
- Philadelphia, Pennsylvania
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- respanatx.com
- Total Funding
- $31.6M
- Last Round
- $20.0M Series BMar 2026
- Rounds
- 3
About
Respana Therapeutics is a preclinical-stage biopharmaceutical company developing host-directed therapeutics to modulate dysregulated immune responses following respiratory viral infections such as influenza, RSV, and coronavirus. The company's lead program is a monoclonal antibody candidate licensed from Penn State University, designed to address post-infectious pulmonary complications with validated preclinical survival data.
Summary
Respana Therapeutics, Inc is a Biotech company based in Philadelphia, United States, founded in 2018. It has raised $31.6M in total across 3 rounds, most recently a $20.0M Series B round in Mar 2026.
Funding History
Mar 2026
Sign up to see all 3 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/respana-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/respana-therapeutics-inc" alt="Respana Therapeutics, Inc on Indexed.vc" width="260" height="76" /></a>